Planned website maintenance is taking place from 11:00 pm AEDT on Friday 30 October to 6:00 am AEDT on Saturday 31 October 2026. Some pages may be temporarily unavailable. If issues continue outside this time, please contact us.
AusPAR: Vaxneuvance
Australian Public Assessment Report
Device/Product Name
Vaxneuvance
Active ingredients
Pneumococcal 15-valent conjugate vaccine (CRM197 protein), adsorbed
AusPAR Date
Published
Submission Number
PM-2022-00382-1-2
Submission Type
Extension of indication
Decision
Approved